Patent holdings for IPC class A61K 38/31

Total number of patents in this class: 277

10-year publication summary

19
32
20
24
25
24
29
16
21
1
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Novartis AG
11234
22
Amryt Endo, Inc.
53
18
Camurus AB
144
17
Ipsen Pharma S.A.S.
387
9
Salix Pharmaceuticals, Inc.
91
7
BCN Peptides, S.A.
29
6
Mondobiotech Laboratories AG
311
6
Otsuka Pharmaceutical Co., Ltd.
1545
6
The Scripps Research Institute
1353
6
Rani Therapeutics, LLC
190
5
Recordati AG
53
5
Mayo Foundation for Medical Education and Research
3126
4
Glytech, Inc.
70
4
Nbo Pharma LLC
4
4
Evonik Corporation
105
3
The Trustees of Columbia University in the City of New York
3529
3
Antisense Therapeutics Ltd.
31
3
Italfarmaco SpA
140
3
New York University
1690
3
Tyme, Inc.
46
3
Other owners 140